Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
01 1FARMAK, a.s
02 1Axplora
03 1EUROAPI
04 1Sanofi
05 1LGM Pharma
06 1Jai Radhe Sales
07 1HRV Global Life Sciences
08 1Nortec Quimica
09 1Zeon Pharma Industries India Pvt Ltd
10 1Aarti Drugs
11 1Active Pharma
12 1Assia Chemical Industries Ltd
13 2Aurobindo Pharma Limited
14 1Boehringer Ingelheim GmbH
15 1CHEMO
16 1Cadila Pharmaceuticals
17 1Cambrex Corporation
18 1Centaur Pharmaceuticals
19 1Cipla
20 1DEAFARMA
21 1Divis Laboratories
22 1Formil Quimica Ltd
23 1Gador SA
24 2Glenmark Life Sciences
25 1Glenmark Pharmaceuticals
26 1IIQUIAP
27 1Ipca Laboratories
28 1Lake Chemicals
29 2Lunan Pharmaceutical
30 1Lupin Ltd
31 1Orchid Pharma
32 1Otto Brandes
33 2Permachem Asia, Ltd
34 2Precise Group
35 1Quimica Sintetica
36 1RANBAXY LABORATORIES LIMITED
37 1SYNTHON Chemicals GmbH & Co. KG
38 1Sagami Chemical Industry
39 1Sai Tech Pharmaceuticals Pvt Ltd
40 2Sun Pharmaceutical Industries Limited
41 1Synthelabo Tanabe Chimie
42 1Synthon Pharmaceuticals
43 2TAPI Technology & API Services
44 1Teva Pharmaceutical Industries
45 1Tianish Laboratories
46 1Torrent Pharmaceuticals Limited
47 2UQUIFA
48 1Unichem Laboratories Limited
49 1Viatris
50 1Wockhardt
51 1YUNG ZIP CHEMICAL INDUSTRIAL
52 1Zentiva
53 1Zydus Lifesciences
54 1Blank
01 1Argentina
02 2Brazil
03 2China
04 2Czech Republic
05 3France
06 4Germany
07 28India
08 4Israel
09 1Italy
10 4Japan
11 1Mexico
12 1Netherlands
13 4Spain
14 1Taiwan
15 3U.S.A
16 1Blank
01 18Active
02 16Inactive
03 28Blank
01 1Expired
02 16Valid
03 5Withdrawn by Holder
04 40Blank
01 1218MF10589
02 1218MF10742
03 1218MF10863
04 1219MF10328
05 1222MF10220
06 1222MF10264
07 1223MF10007
08 1227MF10236
09 1227MF10247
10 1230MF10139
11 1301MF10096
12 1306MF10046
13 50Blank
01 1WC-0017
02 1WC-0031
03 1WC-0057n
04 1WC-0062
05 1WC-0101
06 1WC-0107
07 1WC-0118
08 1WC-0168
09 1WC-0201
10 1WC-0219
11 1WC-236
12 51Blank
Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-04-11
Pay. Date : 2019-04-05
DMF Number : 15486
Submission : 2001-06-21
Status : Active
Type : II
Certificate Number : CEP 2000-319 - Rev 05
Issue Date : 2024-02-02
Type : Chemical
Substance Number : 1280
Status : Valid
Registration Number : 218MF10589
Registrant's Address : Na vlcinci 16/3 Klasterni Hradisko 779 00 Olomouc Czech Republic
Initial Date of Registration : 2006-06-22
Latest Date of Registration : --
NDC Package Code : 63278-0490
Start Marketing Date : 2006-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Korea Pharmaceutical Co., Ltd.
Registration Date : 2021-03-09
Registration Number : 20200515-209-J-477(2)
Manufacturer Name : Farmak, as
Manufacturer Address : Na vlcinci 16/3, Klasterni Hradisko, 779 00 Olomouc, Czech Republic
Available Reg Filing : ASMF |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11764
Submission : 1995-12-05
Status : Inactive
Type : II
Registration Number : 219MF10328
Registrant's Address : 82 Avenue Raspail 94250 Gentilly (FRANCE)
Initial Date of Registration : 2007-11-05
Latest Date of Registration : --
Registrant Name : Handok Co., Ltd.
Registration Date : 2021-03-22
Registration Number : 20210322-209-J-901
Manufacturer Name : Sanofi Chimie
Manufacturer Address : 45, chemin de Météline Boîte Postale 15 04201 Sisteron Cedex, France
Available Reg Filing : ROW |
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20984
Submission : 2007-10-30
Status : Active
Type : II
Certificate Number : CEP 2001-071 - Rev 05
Issue Date : 2024-03-28
Type : Chemical
Substance Number : 1280
Status : Valid
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15131
Submission : 2000-11-08
Status : Inactive
Type : II
Certificate Number : R1-CEP 2003-144 - Rev 03
Issue Date : 2020-06-17
Type : Chemical
Substance Number : 1280
Status : Valid
NDC Package Code : 52286-0004
Start Marketing Date : 2009-11-05
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
We have 53 companies offering Zolpidem Tartrate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?